Intelligence / B2B SaaS / Acquisitions / Impact Biomedical INC.
M&Awas acquired (SEC 8-K)18 Nov 2026
Impact Biomedical INC.
18 Nov 2026: Was acquired (SEC 8-K) · Pharma and biotech. Recorded in the SEC EDGAR full-text search.
- Filed
- 18 Nov 2026
- Ticker
- IBO
- Role
- Was acquired
- Sector
- Pharma and biotech
- Sic
- 2834
- Items
- 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
- Summary
- Pursuant to the Merger Agreement, on November 17, 2026 (the " Closing Date "), (i) Merger Sub merged with and into the Company (the " Merger "), with the Company continuing as the surviving corporation and as a wholly-owned subsidiary of PubCo (the " Surviving Corporation "), and (ii) simultaneously with or immediately
- Location
- West Henrietta, NY
- State
- New York
- Country
- United States
- SEC CIK
- 1834105
- Reference
- 0001493152-26-053017
What this signal means
Integration means consolidating tools and vendors: the buyer re-platforms the target, and an acquired company's stack is reviewed by its new owner.
- Completed an acquisition leads with 189 of 292, then Sold assets or a business (82).
- 103 added in the 30 days to 19 Nov 2026.
Reach them with AOS
Find the decision makers at Impact Biomedical INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this m&a signal, for your approval.
More in Was acquired
Acquisitions
6 NovBowman Consulting Group Ltd.was acquired (SEC 8-K) · Business servicesM&A2 NovKenvue Inc.was acquired (SEC 8-K) · ManufacturingM&A2 NovLiveRamp Holdings, Inc.was acquired (SEC 8-K) · Software and ITM&A2 NovSupernus Pharmaceuticals, INC.was acquired (SEC 8-K) · Pharma and biotechM&A26 OctNathans Famous, INC.was acquired (SEC 8-K) · Wholesale and retailM&A26 OctWeave Communications, Inc.was acquired (SEC 8-K) · Software and ITM&A
Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 2.01 (completion of an acquisition or disposition of assets) filed with the SEC in the last 90 days. The role (buyer, company acquired, seller) is read from the filing's own wording, which is quoted on each row. AOS shows what the public record says; it does not verify or endorse the company.